For the details of SCHOLTZ & COMPANY, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/scholtz+%26+company%2C+llc/current-portfolio/portfolio

Scholtz & Company, Llc initiated holding in Vimeo Inc. The purchase prices were between $40 and $58, with an estimated average price of $45.85. The stock is now traded at around $33.160000. The impact to a portfolio due to this purchase was 1.51%. The holding were 90,179 shares as of 2021-06-30.

Scholtz & Company, Llc initiated holding in Generac Holdings Inc. The purchase prices were between $289.18 and $415.15, with an estimated average price of $335.09. The stock is now traded at around $400.320000. The impact to a portfolio due to this purchase was 1.3%. The holding were 9,108 shares as of 2021-06-30.

Scholtz & Company, Llc initiated holding in Renalytix PLC. The purchase prices were between $23.56 and $34.25, with an estimated average price of $29.85. The stock is now traded at around $25.570000. The impact to a portfolio due to this purchase was 0.93%. The holding were 87,975 shares as of 2021-06-30.

Scholtz & Company, Llc initiated holding in Illumina Inc. The purchase prices were between $372.84 and $481.5, with an estimated average price of $413.01. The stock is now traded at around $486.710000. The impact to a portfolio due to this purchase was 0.2%. The holding were 1,251 shares as of 2021-06-30.

Scholtz & Company, Llc initiated holding in Intellia Therapeutics Inc. The purchase prices were between $60.88 and $161.91, with an estimated average price of $77.89. The stock is now traded at around $149.320000. The impact to a portfolio due to this purchase was 0.16%. The holding were 2,945 shares as of 2021-06-30.

Scholtz & Company, Llc initiated holding in Beam Therapeutics Inc. The purchase prices were between $64.12 and $128.71, with an estimated average price of $79.66. The stock is now traded at around $101.950000. The impact to a portfolio due to this purchase was 0.13%. The holding were 2,945 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in Netflix Inc by 137.87%. The purchase prices were between $484.98 and $555.31, with an estimated average price of $511.62. The stock is now traded at around $546.880000. The impact to a portfolio due to this purchase was 0.92%. The holding were 8,706 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in Advanced Micro Devices Inc by 51.34%. The purchase prices were between $73.09 and $93.93, with an estimated average price of $80.78. The stock is now traded at around $104.650000. The impact to a portfolio due to this purchase was 0.76%. The holding were 69,256 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in IAA Inc by 54.75%. The purchase prices were between $53.33 and $63.34, with an estimated average price of $57.38. The stock is now traded at around $51.710000. The impact to a portfolio due to this purchase was 0.73%. The holding were 110,078 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in Air Products & Chemicals Inc by 40.84%. The purchase prices were between $281.34 and $305.66, with an estimated average price of $293.32. The stock is now traded at around $267.440000. The impact to a portfolio due to this purchase was 0.7%. The holding were 24,530 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in Aspen Group Inc by 82.08%. The purchase prices were between $4.77 and $7.37, with an estimated average price of $5.71. The stock is now traded at around $5.790000. The impact to a portfolio due to this purchase was 0.38%. The holding were 379,050 shares as of 2021-06-30.

Scholtz & Company, Llc added to a holding in Trex Co Inc by 86.20%. The purchase prices were between $91.54 and $109.95, with an estimated average price of $100.67. The stock is now traded at around $108.540000. The impact to a portfolio due to this purchase was 0.17%. The holding were 10,239 shares as of 2021-06-30.

Scholtz & Company, Llc sold out a holding in Teladoc Health Inc. The sale prices were between $132.71 and $192.38, with an estimated average price of $162.47.

Scholtz & Company, Llc sold out a holding in Grayscale Ethereum Trust (ETH) Units. The sale prices were between $17.89 and $40, with an estimated average price of $25.59.

Scholtz & Company, Llc sold out a holding in DraftKings Inc. The sale prices were between $40.99 and $63.8, with an estimated average price of $53.

Scholtz & Company, Llc sold out a holding in Fiserv Inc. The sale prices were between $106.59 and $126.55, with an estimated average price of $116.37.

Scholtz & Company, Llc sold out a holding in DocuSign Inc. The sale prices were between $180.16 and $284.48, with an estimated average price of $222.68.

Scholtz & Company, Llc reduced to a holding in The Joint Corp by 66.27%. The sale prices were between $45.58 and $83.92, with an estimated average price of $61.7. The stock is now traded at around $89.430000. The impact to a portfolio due to this sale was -1.53%. Scholtz & Company, Llc still held 42,025 shares as of 2021-06-30.

Scholtz & Company, Llc reduced to a holding in Progyny Inc by 65.61%. The sale prices were between $44.51 and $64.95, with an estimated average price of $55.95. The stock is now traded at around $46.440000. The impact to a portfolio due to this sale was -1.31%. Scholtz & Company, Llc still held 40,288 shares as of 2021-06-30.

Scholtz & Company, Llc reduced to a holding in Match Group Inc by 26.65%. The sale prices were between $136.81 and $164.27, with an estimated average price of $146.27. The stock is now traded at around $132.660000. The impact to a portfolio due to this sale was -0.37%. Scholtz & Company, Llc still held 19,176 shares as of 2021-06-30.

Scholtz & Company, Llc reduced to a holding in Grayscale Bitcoin Trust by 60.7%. The sale prices were between $27.45 and $54.93, with an estimated average price of $38.91. The stock is now traded at around $39.580000. The impact to a portfolio due to this sale was -0.32%. Scholtz & Company, Llc still held 10,900 shares as of 2021-06-30.

Scholtz & Company, Llc reduced to a holding in Workday Inc by 29.14%. The sale prices were between $221.24 and $265.93, with an estimated average price of $240.65. The stock is now traded at around $235.950000. The impact to a portfolio due to this sale was -0.2%. Scholtz & Company, Llc still held 5,227 shares as of 2021-06-30.

Scholtz & Company, Llc reduced to a holding in Pacific Biosciences of California Inc by 35.34%. The sale prices were between $22.3 and $36.02, with an estimated average price of $29.19. The stock is now traded at around $28.000000. The impact to a portfolio due to this sale was -0.04%. Scholtz & Company, Llc still held 6,165 shares as of 2021-06-30.